Condition
    Moderate Evidence
    Effectiveness 3/5

    Alpha Lipoic Acid (ALA) for Nerve Pain (Neuropathy)

    Alpha-lipoic acid has the best supplement evidence for neuropathy — multiple trials in diabetic nerve damage show symptom and nerve-conduction improvement — though the strongest results came from intravenous dosing, and treating the underlying cause remains essential.

    Overview

    Alpha-lipoic acid has the best supplement evidence for neuropathy — multiple trials in diabetic nerve damage show symptom and nerve-conduction improvement — though the strongest results came from intravenous dosing, and treating the underlying cause remains essential.

    Verdict

    Mixed evidence

    How It Works

    ALA is a potent mitochondrial antioxidant that regenerates other antioxidants (vitamin C, E, glutathione), improves blood flow to nerves, and reduces the oxidative stress that drives diabetic nerve damage. It also improves insulin sensitivity, addressing part of the root cause in diabetes.

    Dosing & Protocol

    Typical dose

    Recommended dose
    600 mg daily, away from food for better absorption
    Expected timeframe
    3-5 weeks for symptom changes; months for nerve function

    Protocol

    form
    Racemic ALA, the form used in the trials
    timing
    Empty stomach, morning
    duration
    Judge at 5 weeks; ALADIN data supports continuing for 4 years in responders
    titration
    Do not go above 600 mg orally; the NATHAN and SYDNEY programmes found higher doses added side effects without extra benefit
    measurement
    Total Symptom Score for burning, tingling, numbness and prickling at baseline and week 5
    starting dose
    600 mg once daily, 30 minutes before breakfast - this is the trial dose, no build-up needed

    Evidence

    What the studies say

    The SYDNEY and NATHAN trial programs showed significant symptom improvement in diabetic neuropathy, with IV dosing producing the largest effects; oral 600 mg daily shows more modest but real benefit. The ALADIN trials support long-term use for slowing progression. Evidence in non-diabetic neuropathy is sparse. Tight glucose control and (when relevant) B12 repletion remain the definitive disease-modifying steps.

    A Comprehensive Review of Safety, Efficacy, and Indications for the Use of Alpha-Lipoic Acid and Acetyl-L-Carnitine in Neuropathic Pain

    Score: 5/10
    2024
    systematic_review

    Aldendail CF, Chen P, Dibble HS +1 more

    Meta-analysis of randomized controlled trials demonstrates that ALA can significantly improve neuropathic pain and nerve conduction velocity.

    View source

    Systematic review of treatments for diabetic peripheral neuropathy

    Score: 8/10
    2016
    meta_analysis

    Çakici N, Fakkel TM, van Neck JW +1 more

    In the meta-analysis of trials of α-lipoic acid versus placebo, total symptom score was reduced by -2.45 (95% CI -4.52; -0.39) with 600 mg i.v. α-lipoic acid

    View source

    Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy

    Score: 6/10
    2018
    meta_analysis

    Wang X, Lin H, Xu S +1 more

    Compared to epalrestat monotherapy, ALA 600 mg/d once a day (qd) combined with epalrestat 50 mg three times a day (tid) augmented the total effectiveness rate (14 days - risk ratio [RR]: 1.40, 95% CI: 1.16-1.69

    View source

    Safety

    Caveats

    Can lower blood sugar — caution with diabetes medication (monitor for hypoglycaemia). Take away from minerals, which chelate it. Rarely causes rash or GI upset.

    Less likely to help if

    People with compressive or entrapment neuropathies, chemotherapy-induced neuropathy, and those with severe long-standing axonal loss.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.